News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TJAB Forms Drug Development JV With Antisense of Australia



7/20/2012 10:06:57 AM

by Richard Daverman, PhD

July 19, 2012 -- Tianjin International Joint Academy of Biotechnology and Medicine (TJAB) has formed a JV with Antisense Therapeutics of Australia to develop a drug discovered by ANP. The drug, ATL1102, is aimed at multiple sclerosis, stem cell mobilization and asthma. TJAB will be responsible for marketing in China and Hong Kong, while ANP will retain those duties for the rest of the world. More details....

Stock Symbol: (ASX: ANP)


Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES